Overcoming mTOR resistance mutations with a new-generation mTOR inhibitorVanessa Rodrik-Outmezguine, Kevan M. Shokat, Masanori Okaniwa et al.|Nature|2016Cited by 483
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancerZhan Yao, Raffaella Sordella|Proceedings of the National Academy of Sciences|2010Cited by 385
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK DependenceMoriah H. Nissan, David B. Solit, Helen Won et al.|Cancer Research|2014Cited by 310
Death effector domain DEDa, a self‐cleaved product of caspase‐8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase‐8 expression via a p53‐dependent mechanismZhan Yao, Mian Wu|The EMBO Journal|2007Cited by 31